Increased Risk for ESBL-Producing Bacteria from Co-administration of Loperamide and Antimicrobial Drugs for Travelers’ Diarrhea1

Details

• Alternative Title:
  Emerg Infect Dis
• Personal Author:
  Kantele, Anu ; Mero, Sointu ; Kirveskari, Juha ; Lääveri, Tinja
• Description:
  Antimicrobial drug treatment of travelers' diarrhea is known to increase the risk for colonization with extended-spectrum β-lactamase-producing Enterobacteriaceae. Among 288 travelers with travelers' diarrhea, the colonization rate without medications was 21%. For treatment with loperamide only, the rate was 20%; with antimicrobial drugs alone, 40%; and with loperamide and antimicrobial drugs, 71%.
• Subjects:
  AMD Antibiotic Resistance Antibiotics Antidiarrheal Antimicrobial Drugs Antimicrobial Resistance Diarrhea Dispatch ESBL Extended-spectrum Beta-lactamase–producing Enterobacteriaceae Increased Risk For ESBL-Producing Bacteria From Co-administration Of Loperamide And Antimicrobial Drugs For Travelers’ Diarrhea Loperamide Travel Travelers’ Diarrhea Travel Health Travel Medicine

  More +
• Source:
  Emerg Infect Dis. 22(1):117-120.
• Pubmed ID:
  26691898
• Pubmed Central ID:
  PMC4696706
• Document Type:
  Journal Article
• Volume:
  22
• Issue:
  1
• Collection(s):
  Emerging Infectious Diseases
• Main Document Checksum:
  urn:sha256:4d7aa3c1af53bbf02d395d576b1a587f1b174ea7507f883f4990979dc55b4532
• Download URL:
  https://stacks.cdc.gov/view/cdc/37286/cdc_37286_DS1.pdf
• File Type:
  [PDF - 465.29 KB ]